Cytopathology
Cytopathology specimens most appropriate for the diagnosis of TB are fine needle aspiration biopsies (FNABs). A presumptive diagnosis of TB may be suggested on other specimens such as pleural and pericardial effusion samples, ascitic fluid, cervicovaginal (Pap) smears, or sputum, but more effective methods such as fluorescent smear microscopy or culture are available to this end. These specimen types are more commonly submitted to the
cytopathology laboratory to exclude or diagnose malignancy. In children the difficulty in obtaining a sputum specimen is well documented, and, although induced sputum may provide an adequate specimen, this requires skill and may be a source of nosocomial
infection for
health workers. Alternative specimens may be aspirates from the nasopharynx, trachea, and stomach, which may not be well tolerated. Hospitalized patients may undergo bronchoscopy and washings and brushings, and
bronchoalveolar lavage (BAL) specimens may be submitted to the cytology laboratory. This is usually in addition to the specimens submitted to
microbiology for direct microscopy and culture. Adequate clinical
information including the origin of the specimen submitted, age and gender of the patient, and duration of symptoms greatly enhances the diagnosis proffered by the pathologist. The immune status of the patient is essential, if known to the clinician, as specimens from immunocompromised patients may show significantly altered cytomorphology compared with the classical cytomorphology of immunocompetent patients.
High Impact List of Articles
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Preventive chemotherapy for schistosomiasis and soil-transmitted helminthiasis by cotreatment with praziquantel and albendazole
J Russell Stothard, Amaya Bustinduy & Antonio Montresor
Review: Clinical Trail Outcomes: Clinical Investigation
-
Preventive chemotherapy for schistosomiasis and soil-transmitted helminthiasis by cotreatment with praziquantel and albendazole
J Russell Stothard, Amaya Bustinduy & Antonio Montresor
Review: Clinical Trail Outcomes: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
-
Recombinant von Willebrand factor: is this the answer for treatment of von Willebrand disease? ***Recombinant VWF treatment
Steve Keeney
Editorial: Clinical Investigation
Relevant Topics in Clinical